Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. - Wikidata - awgldk - TriplyDB

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.

http://www.wikidata.org/entity/Q33205413

about

AT2 receptor activities and pathophysiological implications Prevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke models Therapeutic potential of the renin angiotensin system in ischaemic stroke Direct angiotensin AT2 receptor stimulation using a novel AT2 receptor agonist, compound 21, evokes neuroprotection in conscious hypertensive rats The effects of poststroke captopril and losartan treatment on cerebral blood flow autoregulation in SHRsp with hemorrhagic stroke.Direct stimulation of angiotensin II type 2 receptor enhances spatial memory Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.Postischemic administration of angiotensin II type 1 receptor blocker reduces cerebral infarction size in hypertensive rats.Memory is preserved in older adults taking AT1 receptor blockers.GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in Mice Elevated blood pressure in the acute phase of stroke and the role of Angiotensin receptor blockers.Neuroprotective effect of anthocyanin on experimental traumatic spinal cord injury Deletion of mitochondrial anchoring protects dysmyelinating shiverer: implications for progressive MS.Candesartan restores pressure-induced vasodilation and prevents skin pressure ulcer formation in diabetic mice.Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.Role of blood cell-associated angiotensin II type 1 receptors in the cerebral microvascular response to ischemic stroke during angiotensin-induced hypertension Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?Perinatal nicotine exposure increases vulnerability of hypoxic-ischemic brain injury in neonatal rats: role of angiotensin II receptors.Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo.Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.Targeting angiotensin II type I receptors to reduce the risk of stroke in patients with hypertension.Roles of Brain Angiotensin II in Cognitive Function and Dementia.The Angiotensin II Type 2 Receptor in Brain Functions: An Update.AT1 receptor antagonism is proangiogenic in the brain: BDNF a novel mediator.The pathophysiologic role of the brain renin-angiotensin system in stroke protection: clinical implications.Role of angiotensin receptor blockers in the prevention and management of ischaemic stroke.Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion Candesartan pretreatment is cerebroprotective in a rat model of endothelin-1-induced middle cerebral artery occlusion.Inhibition of the renin-angiotensin system and target organ protection.Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice.AT(2) receptor and tissue injury: therapeutic implications.Effects of angiotensin II receptor blockers on dementia.Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?The past, present and future of angiotensin II type 2 receptor stimulation.The angiotensin II type 2 receptor in cardiovascular disease.The angiotensin II type 2 receptor in the brain.Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.The neuroprotective effects of apocynin.Angiotensin II type 2 receptor agonists: where should they be applied?

P2860

Q26829592-BFC09C43-6A8E-4B27-8791-764DE1FDB4F0 Q27323835-99B6C379-214E-41FB-B2CC-659562CA22CD Q28077553-1E53C617-778E-43D2-A771-507D1223D291 Q28538103-4C1931BE-5C9A-4707-AACB-D09F1BF54132 Q30498347-312BB05D-18D6-49AA-ACCA-D67114BA87A3 Q30504733-F26B5AB7-236A-4F35-A5C8-D026EF065BFF Q30585823-BF6236A6-CF74-4CC6-8516-9FD053924342 Q33403831-89C56C71-31F3-406F-A976-921EBBE3FE06 Q33441240-B8583B9D-5DF5-40E5-8DB2-CE7F5B6E0135 Q33604279-68C0EF6E-3859-4C19-806C-E52264201131 Q33780749-CF1927AE-A513-4CFB-8243-07DEC863C58A Q34595301-986E44F3-3A17-4F23-9219-0CA85709E3D6 Q34993785-9DEC26C5-4AC6-46DD-A4C4-22966EF063A1 Q35236885-7915E78A-B96B-4810-BDCA-103B373A90DB Q35382532-5653473C-1C3F-4818-8D35-8DECD535715C Q35534662-EE4B1897-DC2F-417B-954E-F741A6C8BC3F Q35619265-545FACAE-4395-4AF3-B109-D8548122C885 Q35971305-2F02554A-DF27-4A90-89F1-1EE5DE5128ED Q36195256-ED26C0D2-9D80-4EC7-9CB7-48514C526FBE Q36380230-66A483C7-3D5A-4EA3-AE87-7B1F61DCD96B Q36412546-6C456CB2-1FDF-4B1A-A50E-6DA7F127E153 Q36425956-9C8CFE69-BBD4-431A-8D0E-26265C1142A3 Q36487749-E138394E-320B-435A-9B4F-6AACB9111D54 Q36520049-D0FC1AC8-E64E-429A-B025-955ABFC8DF3A Q36573232-AD107ADF-6EA5-4EB7-BB6D-BCE3C20056E8 Q36836587-3E33F8C7-7AF3-4126-9452-0AB72174E979 Q36979914-5FC03870-B53B-4CB1-80A7-F5D9330F4AA1 Q37196498-BF325EF1-9A23-405C-8C22-B83E023F4DEF Q37342681-5EBF749B-BB38-4ACA-A07C-A8456C57D23C Q37406883-29210BBB-7D9C-4F86-96D8-070E9FD80406 Q37422070-94597927-49F2-4C6B-85EE-C5272F701655 Q37531017-446F0F4A-2878-4289-96D6-157C87382732 Q37591159-E6183FD7-A93F-489A-BADF-079D93AC917B Q37600856-3439CB49-6D37-487A-9B4D-A654E5573CED Q37622572-5DA49E84-B09D-44BC-B858-AC42536A8B60 Q37622575-5DB4A003-01FB-495D-AD4F-52CFE94E5B8A Q37622583-2F4258CE-9548-4A20-ABDE-F19286C613AC Q37822830-A6AE06AA-F53C-4530-B5FB-9DCD8AEFE91C Q37971725-0A7DF426-60C1-4D2F-962C-135019006BBD Q37986143-B217373B-9353-48EA-840A-C172C7BE2805

P2860

Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.

http://www.wikidata.org/entity/Q33205413

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@ast

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@en

type

label

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@ast

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@en

prefLabel

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@ast

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@en

P1433

Q33205413-423D22C9-8B07-4FA2-A714-5856217B608C

P1476

Q33205413-906B8C38-4B9F-4FB8-9FA6-79DA20D8C970

P2093

Q33205413-2207ACC1-FAB0-4B45-BFD3-0CBA72EF0F77

Q33205413-527D739F-61CA-4FB6-9491-38C20D74ECA8

Q33205413-87B0D1E9-3FB5-4C62-8B12-04A074BA4836

Q33205413-89C2065B-CDAA-4951-B99E-0737FFC9F671

Q33205413-8AA50AAD-9FB0-49B0-ADD3-FCB7B0708964

Q33205413-9C08AF74-B4D7-4D32-971B-11AA7444CEB1

Q33205413-E182532B-5D55-404F-81D3-8BF40F302384

Q33205413-E61489FD-5E2C-454B-9F41-0C3EED4E1EA5

Q33205413-FBDA078D-5C1E-4D4F-BAC3-25A65E2A674E

P304

Q33205413-8BBDCC83-4A6B-4C9E-A676-B9C434A217B6

P31

Q33205413-5CD8123D-2924-467C-8B5C-753C9C00B1FF

P356

Q33205413-2D2571BB-3E01-47AA-85F3-3E1BF1868922

P407

Q33205413-0A5846E4-140B-4A47-8111-918ADFFC3DAA

P433

Q33205413-E3026977-5242-47DD-AFF3-1014B18C84A1

P478

Q33205413-639A1CC6-354D-4DF1-BA9A-06695EB33F4E

P577

Q33205413-593631A5-C891-46CF-9227-81D09F7657DE

P5875

Q33205413-5CCF679B-5ADF-4F48-8694-8E18F79C2E11

P698

Q33205413-32C8FFC3-78DC-45A9-9170-60949E2153EE

P921

Q33205413-E067E7F5-7077-46D4-A8D9-55C77D18BD23

P356

01.CIR.0000138848.58269.80

P1433

P1476

Possible inhibition of focal c ...... I type 2 receptor stimulation.

@en

P2093

Ayumi Ide

http://www.w3.org/2001/XMLSchema#string

Hong-Wei Liu

http://www.w3.org/2001/XMLSchema#string

Masahiro Sakanaka

http://www.w3.org/2001/XMLSchema#string

Masaru Iwai

http://www.w3.org/2001/XMLSchema#string

Masatsugu Horiuchi

http://www.w3.org/2001/XMLSchema#string

Rui Chen

http://www.w3.org/2001/XMLSchema#string

Ryuji Hata

http://www.w3.org/2001/XMLSchema#string

Shoko Okamoto

http://www.w3.org/2001/XMLSchema#string

Tetsuya Shiuchi

http://www.w3.org/2001/XMLSchema#string

P304

843-848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000138848.58269.80

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8421583

http://www.w3.org/2001/XMLSchema#string

P698

15289370

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction